This site looks much better when viewed in a Web Standards compliant browser. You really should upgrade to a Web Standards compliant browser, it will make your life a little better.

The University of Montana - Missoula

The College of Health Professions and Biomedical Science

Michael P. Rivey, M.S., BCPS

Professor, Pharmacy Practice

Michael P. Rivey

Campus Office

Campus Office: SB 333
Phone: (406) 243-6796
Fax: (406) 243-4353
E-Mail: michael.rivey (at) umontana.edu

Practice Site

Name: Community Medical Center
Address: 2827 Fort Missoula Road, Missoula, MT 59804
Phone: (406) 728-4100 (x7605)

Education & Training

  • Board Certified Pharmacotherapy Specialist, 1991 - present
  • M.S. Pharmacy, University of Iowa (1982)
  • B.S. Pharmacy, University of Iowa (1974)

Clinical & Research Interests

  • Thromboembolic Disease
  • Adult Internal Medicine
  • Neurological Disease

Teaching & Preceptor Activities

  • PHAR 452: Therapeutics II
  • PHAR 552/3: Therapeutics III (Course Coordinator)
  • PHAR 472/571/574: Integrated Studies
  • Preceptor: Inpatient Clinical Clerkship (plus various specialty clerkships), Community Medical Center

Key Publications & Presentations

Keeley KA, Rivey MP, Allington DR. Natalizumab for the Treatment of Multiple Sclerosis and Crohn’s Disease. Annals of Pharmacotherapy 2005 (accepted for publication)

Rivey MP, Allington DR, Mathis JB. Evaluation of a risk assessment approach to venous thromboembolism (VTE) prophylaxis in medically ill patients. Poster (refereed) accepted for presentation at ACCP Annual Meeting, San Francisco, CA. October 25, 2005.

Brophy DF, Dougherty JA, Garrelts JC, Parish RC, Rivey MP, Stumpf JL, Taylor CT, Mathis AS. Venous Thromboembolism Prevention in Acutely Ill Nonsurgical Patients. Annals of Pharmacotherapy 2005;39:1318-24.

Keeley KA, Mathis JB, Rivey MP. Medication Reconciliation in Hospitalized Patients. The New Montana Pharmacist 2005; summer issue: pp 6-7. (nonrefereed)

Keeley K, Rivey MP, Allington D, Mathis B. Pharmacist-conducted medication histories. Poster presented to ASHP Midyear Clinical Meeting, Orlando, Fl. December 8, 2004.

Rivey MP, Allington DR. Case 146: Gastrointestinal Infections with Enterotoxigenic Bacterium. PharmPrep, 2nd edition. American Society of Health-System Pharmacists, Bethesda, MD. pp 96-98. 2004.

Rivey MP, Allington DR. Case 147: Gastrointestinal Infections with Enterotoxigenic Bacterium. PharmPrep, 2nd edition. American Society of Health-System Pharmacists, Bethesda, MD. published on electronic CD medium. 2004.

Hunt K and Rivey MP. Evaluation of venous thromboembolism (VTE) prophylaxis in surgical and hospitalized patients. Presentation (refereed) to ASHP Western States Residency Conference, Monterey, CA, May 2004.

Rivey MP, Hunt KM, Allington DR. Evaluation of thrombosis risk assessment in surgical patients. Poster (refereed) presented to 2nd ACCP-ESCP International Congress on Clinical Pharmacy, Paris, France, April 29, 2004

Rivey MP, Allington DR, Reinivaara-Hall T, Mathis JB, Miller DC, McKernan JL. Development of a pharmacy practice residency with a focus in pain management in a small hospital. Poster (refereed) presented to ASHP Midyear Clinical Meeting, New Orleans, LA, December 9, 2003.

Carter JT, Allington DR, Rivey MP. Use of concept maps to assess clerkship students’ knowledge of stroke. Poster (refereed) presented at AACP Annual Meeting, Minneapolis, MN, July 12, 2003.

Carter JT, Miller SJ, Rivey MP. Student performance on negatively versus positively worded multiple choice questions in a therapeutics course. Poster (refereed) presented at AACP Annual Meeting, Kansas City, MO, July, 2002.

Recent Presentations

Rivey MP. Update on Prevention of Venous Thromboembolism. Presented to North Valley Hospital Grand Rounds, Whitefish, MT. February 9, 2005. Sponsored by Aventis, Inc.

Rivey MP. Update on Prevention of Venous Thromboembolism. Presented to Community Medical Center CE Education Series, Missoula, MT. January 26, 2005. Sponsored by Aventis, Inc.

Rivey MP. Update: Prevention and Treatment of Thrombosis. Presentation to Montana Pharmacy Association (MPA) Fall Meeting, Whitefish, MT. October 23, 2004. 2 hours.

Rivey MP and Gong WC. Training Residents in Self-Evaluation. Invited presentation to 2004 ASHP National Residency Preceptors Conference. Presented two 1.5 hr sessions. San Diego, CA. August 14, 2004

Invited participant & speaker for program “Advancing Into a New Era of Anticoagulant Therapy” Program Sponsored by: The Johns Hopkins University School of Medicine and the University of Tennessee College of Pharmacy. Supported by grant from AstraZeneca Pharmaceuticals. One of 56 national speakers for program.

  • September 18-19, 2003. Speaker Review Meeting, Chicago, Ill. participant
  • December 17, 2003. Speaker for program. Seattle, WA 1.5 hours
  • March 3, 2004 Speaker for program. Missoula, MT 1.5 hours
  • March 16, 2004 Speaker for program, Spokane, WA 1.5 hours

Rivey MP. Establishing a Pharmacy Residency. Presented to UM Clinical Instructors’ Meeting, Univ. of Montana, Missoula. September 12, 2003

Presentations to Pharmacy Continuing Education

Rivey MP. Asthma: Diagnosis and Severity Classification METNET (11 sites) 1 hour, Missoula, MT, 4/6/2004.

Rivey MP. Update in Anticoagulation. Presented to the University of Montana Pharmacy Continuing Education Programs. METNET (11 sites) 1 hour, Missoula, MT. 2/29/2004

Rivey MP. Advances in the Treatment of Chronic Viral Hepatitis. Presented to University of Montana Pharmacy Continuing Education Programs. METNET (8 sites) 1 hour, Bozeman, MT, 2/23/2003.